{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-6/paragraph-2",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-6/paragraph-2.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/6/paragraph/2",
  "kind": "paragraph",
  "number": "2",
  "heading": "Dispensing of drugs and appliances ordered by another prescriber",
  "text": "(1) In this paragraph, “signed” includes signature with a prescriber's advanced electronic signature.\n(2) Subject to the following provisions of this Schedule, where—\n(a) any person presents to a dispensing doctor (D) a non-electronic prescription form which contains—\n(i) an order for drugs, not being Scheduled drugs, or for appliances, not being restricted availability appliances, signed by a prescriber other than D,\n(ii) an order for drugs specified in Schedule 2 to the Prescription of Drugs Regulations (drugs, medicines and other substances that may be ordered only in certain circumstances), signed by a prescriber other than D, and including the reference “SLS”, or\n(iii) an order for restricted availability appliances, signed by a prescriber other than D and including the reference “SLS”; ...\n(b) subject to sub-paragraph (4), D receives as a nominated dispensing contractor from the Electronic Prescription Service an electronic prescription form which contains an order of a kind specified in paragraph (a)(i) to (iii) and—\n(i) any person requests the provision of drugs or appliances in accordance with that prescription, or\n(ii) D has previously arranged with the patient that D will dispense that prescription on receipt; or\n(c) any person—\n(i) presents D with an EPS token that relates to an order of a kind specified in paragraph (a)(i) to (iii), and\n(ii) requests the provision of drugs or appliances in accordance with the related electronic prescription form,\nand D is authorised or required by virtue of Part 8 to provide the drugs or appliances so ordered, D must, with reasonable promptness, provide the drugs so ordered, and such of the appliances so ordered as D supplies in the normal course of business.\n(3) Subject to the following provisions of this Schedule, where—\n(a) any person presents to D a non-electronic repeatable prescription which contains—\n(i) an order for drugs, not being Scheduled drugs or controlled drugs within the meaning of the Misuse of Drugs Act 1971 , other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001 (which relate to controlled drugs excepted from certain prohibitions under the Regulations), signed by a prescriber other than D,\n(ii) an order for a drug specified in Schedule 2 to the Prescription of Drugs Regulations, not being a controlled drug within the meaning of the Misuse of Drugs Act 1971, other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001, signed by a prescriber other than D and including the reference “SLS”,\n(iii) an order for appliances, not being restricted availability appliances, signed by a prescriber other than D, or\n(iv) an order for a restricted availability appliance, signed by a prescriber other than D, and including the reference “SLS”,\nand also presents an associated batch issue; ...\n(b) D receives as a nominated dispensing contractor an electronic repeatable prescription from the Electronic Prescription Service which contains an order of a kind specified in paragraph (a)(i) to (iv) and—\n(i) any person requests the provision of drugs or appliances in accordance with that repeatable prescription, or\n(ii) D has previously arranged with the patient that D will dispense that repeatable prescription on receipt; or\n(c) any person—\n(i) presents D with an EPS token that relates to an order of a kind specified in paragraph (a)(i) to (iv), and\n(ii) requests the provision of drugs or appliances in accordance with the related electronic repeatable prescription,\nand D is authorised or required by virtue of Part 8 to provide the drugs or appliances so ordered, D must, with reasonable promptness, provide the drugs so ordered, and such of the appliances so ordered as D supplies in the normal course of business.\n(4) D must not provide under an electronic prescription form a controlled drug within the meaning of the Misuse of Drugs Act 1971, other than a drug which is for the time being specified in Schedules 2 to 5 to the Misuse of Drugs Regulations 2001.\n(5) For the purposes of this paragraph, a non-electronic repeatable prescription for drugs or appliances shall be taken to be presented even if the person who wishes to obtain the drugs or appliances does not present that prescription, where—\n(a) D has that prescription in D's possession; and\n(b) that person presents, or D has in D's possession, an associated batch issue.\n(6) Drugs and appliances provided under this paragraph must be provided in a suitable container.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Word in Sch. 6 para. 2(2)(a) omitted (26.11.2018) by virtue of The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(a)(i)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Sch. 6 para. 2(2)(b) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(a)(ii)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Word in Sch. 6 para. 2(2)(b) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(a)(iii)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Sch. 6 para. 2(2)(c) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(a)(iv)"
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Word in Sch. 6 para. 2(3)(a) omitted (26.11.2018) by virtue of The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(b)(i)"
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Words in Sch. 6 para. 2(3)(b) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(b)(ii)"
    },
    {
      "type": "F",
      "label": "F7",
      "text": "Word in Sch. 6 para. 2(3)(b) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(b)(iii)"
    },
    {
      "type": "F",
      "label": "F8",
      "text": "Sch. 6 para. 2(3)(c) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 9(2)(b)(iv)"
    },
    {
      "type": "F",
      "label": "F9",
      "text": "Words in Sch. 6 para. 2(4) substituted (1.7.2015) by The National Health Service (Amendments to Primary Care Terms of Service relating to the Electronic Prescription Service) Regulations 2015 (S.I. 2015/915), regs. 1, 4(3)"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "Schedule 2 has been amended by S.I. 2004/3215, 2009/2230, 2010/2389 and 2011/680 and 1043."
    },
    {
      "type": "M",
      "label": "M2",
      "text": "1971 c.38; see section 2(1)(a) of that Act, which defines “controlled drug” for the purposes of that Act."
    },
    {
      "type": "M",
      "label": "M3",
      "text": "S.I. 2001/3998. Schedule 4 has been amended by S.I. 2003/1432, 2005/3372, 2007/2154, 2009/3136 and 2012/973, and Schedule 5 has been amended by S.I. 2005/2864."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/6/paragraph/2",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}